clinical trial · NCT00834444
Famciclovir 500 mg Tablets Under Non-Fasting Conditions
Teva Pharmaceuticals USA·phase1·completed·n = 36
HealthyFamciclovir 500 mg TabletsFamvir® 500 mg Tablets
brief summary
The objective of this study is to compare the relative bioavailability of famciclovir 500 mg tablets (Novopharm Limited) with that of FAMVIR® 500 mg tablets (Novartis) in healthy adult subjects under non-fasting conditions.
started
Aug 1, 2004
primary completion
Sep 1, 2004
completion
Sep 1, 2004
last updated
Aug 20, 2024
detailed description
Criteria for Evaluation: FDA Bioequivalence Criteria
Statistical Methods: FDA bioequivalence statistical methods
official title
A Single Dose, Comparative Bioavailability Study of Two Formulations of Famciclovir 500 mg Tablets Under Non-Fasting Conditions
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol